TC Medical(SH:600763) Xin Lang Cai Jing·2026-01-21 02:37Core Viewpoint - Tongce Medical's stock has shown a positive trend with a year-to-date increase of 12.41%, reflecting strong performance in the medical service sector [1][2]. Group 1: Stock Performance - As of January 21, Tongce Medical's stock price reached 45.20 CNY per share, with a market capitalization of 20.217 billion CNY [1]. - The stock has experienced a 4.15% increase over the last five trading days, a 10.19% increase over the last 20 days, and a 6.60% increase over the last 60 days [1]. - The company has seen a net outflow of 12.52 thousand CNY in principal funds, with significant buying and selling activity from large orders [1]. Group 2: Financial Performance - For the period from January to September 2025, Tongce Medical reported a revenue of 2.29 billion CNY, representing a year-on-year growth of 2.56%, and a net profit attributable to shareholders of 514 million CNY, up 3.06% year-on-year [2]. - The company has distributed a total of 392 million CNY in dividends since its A-share listing, with 340 million CNY distributed over the past three years [3]. Group 3: Shareholder Structure - As of January 10, the number of shareholders for Tongce Medical decreased to 90,000, while the average number of circulating shares per person increased by 8.89% to 4,969 shares [2]. - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Medical ETF and Southern Zhongzheng 500 ETF, with some shareholders reducing their holdings [3].